The US is switching to a skin-deep monkeypox vaccine strategy, to save on supplies. Using this new technique, there should be "enough" shots available to vaccinate everyone at risk, federal officials ...
People who are at high risk for monkeypox can now get vaccinated for the virus via intradermal injection after the U.S. Food and Drug Administration authorized the technique. The FDA issued an ...
The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...
The new intradermal technique requires just a fraction of a vaccine per shot. Some states and jurisdictions are hitting early bumps in their rollout of the U.S. government's new approach to expand ...
In a recent study posted to the bioRxiv* preprint server, researchers assessed the efficiency of a controllable self-replicating ribonucleic acid (c-srRNA) vaccine against severe acute respiratory ...
The transition from Monkeypox Inoculation Plan A to Monkeypox Inoculation Plan B has been a smashing success—at least, if you ask federal officials. Just a few weeks ago, the U.S. had nowhere near ...
One solution proposed to the current shortage of monkeypox vaccine has been to consider 'dose sparing' to make supplies stretch further. This involves using one vial of the Imvanex/Jynneos vaccine, ...
Institut Pasteur de Dakar has opened a new front in its push to enable low-cost access to vaccines, teaming up with the medtech company Satio to advance candidates based on intradermal delivery patch ...
The U.S. is now allowing fractional doses of the Jynneos monkeypox vaccine to be administered via an injection that delivers the dose between, rather than under, layers of skin — an effort that will ...
The US Food and Drug Administration (FDA) today authorized intradermal administration of the Jynneos vaccine for the treatment of monkeypox. The process, approved specifically for high-risk patients, ...
The Biden administration will distribute monkeypox vaccine to jurisdictions that adopt a new protocol using one-fifth the regular dose. Critics called the plan “unscientific.” By Sheryl Gay Stolberg ...